|
|
||||||||
Laboratoire de Physiopathologie et de Pharmacologie Cellulaires et Moléculaires, Institut National de la Santé et de la Recherche Médicale CJF96-01, Hôpital Hotel-Dieu, 44093 Nantes, France
We investigated whether high levels of expression of the cystic fibrosis transmembrane conductance regulator (CFTR) would alter the functional properties of newly synthesized recombinant proteins. COS-7, CFPAC-1, and A549 cells were intranuclearly injected with a Simian virus 40-driven pECE-CFTR plasmid and assayed for halide permeability using the 6-methoxy-N-(3-sulfopropyl)quinolinium fluorescent probe. With increasing numbers of microinjected pECE-CFTR copies, the baseline permeability to halide dose dependently increased, and the response to adenosine 3',5'-cyclic monophosphate (cAMP) stimulation decreased. In cells hyperexpressing CFTR, the high level of halide permeability was reduced when a cell metabolism poisoning cocktail was applied to decrease intracellular ATP and, inversely, was increased by orthovanadate. In CFPAC-1 cells investigated with the patch-clamp technique, CFTR hyperexpression led to a time-independent nonrectifying chloride current that was not sensitive to cAMP stimulation. CFPAC-1 cells hyperexpressing CFTR exhibited no outward rectifying chloride current nor inward rectifying potassium current either spontaneously or under cAMP stimulation. We conclude that hyperexpression of recombinant CFTR proteins modifies their properties inasmuch as 1) CFTR channels are permanently activated and not susceptible to cAMP regulation and 2) they lose their capacity to regulate heterologous ionic channels.
cystic fibrosis transmembrane conductance regulator; cystic fibrosis; expression; patch clamp; CFPAC-1 cells; A549 cells; epithelial cells
This article has been cited by other articles:
![]() |
F. Bossard, A. Robay, G. Toumaniantz, S. Dahimene, F. Becq, J. Merot, and C. Gauthier NHE-RF1 protein rescues {Delta}F508-CFTR function Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1085 - L1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Murray, F Potet, C Bellocq, I Baro, W Reardon, H E Hughes, and S Jeffery Mutation in KCNQ1 that has both recessive and dominant characteristics J. Med. Genet., September 1, 2002; 39(9): 681 - 685. [Full Text] [PDF] |
||||
![]() |
F. Kyndt, V. Probst, F. Potet, S. Demolombe, J.-C. Chevallier, I. Baro, J.-P. Moisan, P. Boisseau, J.-J. Schott, D. Escande, et al. Novel SCN5A Mutation Leading Either to Isolated Cardiac Conduction Defect or Brugada Syndrome in a Large French Family Circulation, December 18, 2001; 104(25): 3081 - 3086. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Potet, J. D. Scott, R. Mohammad-Panah, D. Escande, and I. Baro AKAP proteins anchor cAMP-dependent protein kinase to KvLQT1/IsK channel complex Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2038 - H2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Howard, X. Jiang, D. B. Stolz, W. G. Hill, J. A. Johnson, S. C. Watkins, R. A. Frizzell, C. M. Bruton, P. D. Robbins, and O. A. Weisz Forskolin-induced apical membrane insertion of virally expressed, epitope-tagged CFTR in polarized MDCK cells Am J Physiol Cell Physiol, August 1, 2000; 279(2): C375 - C382. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pereon, S. Demolombe, I. Baro, E. Drouin, F. Charpentier, and D. Escande Differential expression of KvLQT1 isoforms across the human ventricular wall Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1908 - H1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Leblais, S. Demolombe, G. Vallette, D. Langin, I. Baro, D. Escande, and C. Gauthier beta 3-Adrenoceptor Control the Cystic Fibrosis Transmembrane Conductance Regulator through a cAMP/Protein Kinase A-independent Pathway J. Biol. Chem., March 5, 1999; 274(10): 6107 - 6113. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mohammad-Panah, K. Gyomorey, J. Rommens, M. Choudhury, C. Li, Y. Wang, and C. E. Bear ClC-2 Contributes to Native Chloride Secretion by a Human Intestinal Cell Line, Caco-2 J. Biol. Chem., March 9, 2001; 276(11): 8306 - 8313. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |